Cargando…

Beta-2 microglobulin is important for disease progression in a murine model for amyotrophic lateral sclerosis

Beta-2 microglobulin (β2m) is an essential component of the major histocompatibility complex (MHC) class I proteins and in the nervous system β2m is predominantly expressed in motor neurons. As β2m can promote nerve regeneration, we investigated its potential role in amyotrophic lateral sclerosis (A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Staats, Kim A., Schönefeldt, Susann, Van Rillaer, Marike, Van Hoecke, Annelies, Van Damme, Philip, Robberecht, Wim, Liston, Adrian, Van Den Bosch, Ludo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857886/ https://www.ncbi.nlm.nih.gov/pubmed/24368896 http://dx.doi.org/10.3389/fncel.2013.00249

Ejemplares similares

Modelling amyotrophic lateral sclerosis: progress and possibilities
por: Van Damme, Philip, et al.
Publicado: (2017)

Rapamycin increases survival in ALS mice lacking mature lymphocytes
por: Staats, Kim A, et al.
Publicado: (2013)

Progranulin is Neurotrophic In Vivo and Protects against a Mutant TDP-43 Induced Axonopathy
por: Laird, Angela S., et al.
Publicado: (2010)

Reducing EphA4 before disease onset does not affect survival in a mouse model of Amyotrophic Lateral Sclerosis
por: Rué, Laura, et al.
Publicado: (2019)

Reduction of ephrin-A5 aggravates disease progression in amyotrophic lateral sclerosis
por: Rué, Laura, et al.
Publicado: (2019)

The multifaceted role of kinases in amyotrophic lateral sclerosis: genetic, pathological and therapeutic implications
por: Guo, Wenting, et al.
Publicado: (2020)

Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival
por: Van Damme, Philip, et al.
Publicado: (2008)

Histone Deacetylase Inhibition Regulates Lipid Homeostasis in a Mouse Model of Amyotrophic Lateral Sclerosis
por: Burg, Thibaut, et al.
Publicado: (2021)

Therapeutic potential of HDAC6 in amyotrophic lateral sclerosis
por: Guo, Wenting, et al.
Publicado: (2017)

The Role of Nucleocytoplasmic Transport Defects in Amyotrophic Lateral Sclerosis
por: Vanneste, Joni, et al.
Publicado: (2021)

Opportunities for histone deacetylase inhibition in amyotrophic lateral sclerosis
por: Klingl, Yvonne E., et al.
Publicado: (2020)

Conditional deletion of Id2 or Notch1 in oligodendrocyte progenitor cells does not ameliorate disease outcome in SOD1(G93A) mice
por: Eykens, Caroline, et al.
Publicado: (2018)

Role and therapeutic potential of liquid–liquid phase separation in amyotrophic lateral sclerosis
por: Pakravan, Donya, et al.
Publicado: (2020)

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
por: Pollari, Eveliina, et al.
Publicado: (2018)

Amyotrophic lateral sclerosis: a clinical review
por: Masrori, P., et al.
Publicado: (2020)

Genetic Rodent Models of Amyotrophic Lateral Sclerosis
por: Van Den Bosch, L.
Publicado: (2011)

Prevention of intestinal obstruction reveals progressive neurodegeneration in mutant TDP-43 (A315T) mice
por: Herdewyn, Sarah, et al.
Publicado: (2014)

Development of Improved HDAC6 Inhibitors as Pharmacological Therapy for Axonal Charcot–Marie–Tooth Disease
por: Benoy, Veronick, et al.
Publicado: (2016)

Exome array analysis of rare and low frequency variants in amyotrophic lateral sclerosis
por: Dekker, Annelot M., et al.
Publicado: (2019)

RNA toxicity in non‐coding repeat expansion disorders
por: Swinnen, Bart, et al.
Publicado: (2019)

Progranulin functions as a cathepsin D chaperone to stimulate axonal outgrowth in vivo
por: Beel, Sander, et al.
Publicado: (2017)

Genetic ablation of IP(3) receptor 2 increases cytokines and decreases survival of SOD1(G93A) mice
por: Staats, Kim A., et al.
Publicado: (2016)

Effect of neurofilament analysis on the diagnostic delay in amyotrophic lateral sclerosis
por: De Schaepdryver, Maxim, et al.
Publicado: (2022)

FUS-induced neurotoxicity in Drosophila is prevented by downregulating nucleocytoplasmic transport proteins
por: Steyaert, Jolien, et al.
Publicado: (2018)

Intracerebroventricular delivery of vascular endothelial growth factor in patients with amyotrophic lateral sclerosis, a phase I study
por: Van Damme, Philip, et al.
Publicado: (2020)

ATXN1 repeat expansions confer risk for amyotrophic lateral sclerosis and contribute to TDP-43 mislocalization
por: Tazelaar, Gijs H P, et al.
Publicado: (2020)

Progranulin reduces insoluble TDP-43 levels, slows down axonal degeneration and prolongs survival in mutant TDP-43 mice
por: Beel, Sander, et al.
Publicado: (2018)

SCFD1 expression quantitative trait loci in amyotrophic lateral sclerosis are differentially expressed
por: Iacoangeli, Alfredo, et al.
Publicado: (2021)

Genetic variability in sporadic amyotrophic lateral sclerosis
por: Van Daele, Sien Hilde, et al.
Publicado: (2023)

Glucose metabolic brain patterns to discriminate amyotrophic lateral sclerosis from Parkinson plus syndromes
por: Devrome, Martijn, et al.
Publicado: (2018)

Whole-genome sequencing reveals a coding non-pathogenic variant tagging a non-coding pathogenic hexanucleotide repeat expansion in C9orf72 as cause of amyotrophic lateral sclerosis
por: Herdewyn, Sarah, et al.
Publicado: (2012)

Mutant FUS causes DNA ligation defects to inhibit oxidative damage repair in Amyotrophic Lateral Sclerosis
por: Wang, Haibo, et al.
Publicado: (2018)

Blood-based biomarkers of inflammation in amyotrophic lateral sclerosis
por: Staats, Kim A., et al.
Publicado: (2022)

The importance of offering early genetic testing in everyone with amyotrophic lateral sclerosis
por: Salmon, Kristiana, et al.
Publicado: (2022)

Tauroursodeoxycholic acid in patients with amyotrophic lateral sclerosis: The TUDCA-ALS trial protocol
por: Albanese, Alberto, et al.
Publicado: (2022)

Protein aggregation in amyotrophic lateral sclerosis
por: Blokhuis, Anna M., et al.
Publicado: (2013)

Structural variation analysis of 6,500 whole genome sequences in amyotrophic lateral sclerosis
por: Al Khleifat, Ahmad, et al.
Publicado: (2022)

RNA-Binding Proteins in Amyotrophic Lateral Sclerosis
por: Zhao, Melody, et al.
Publicado: (2018)

UNC13A in amyotrophic lateral sclerosis: from genetic association to therapeutic target
por: Willemse, Sean W, et al.
Publicado: (2023)

Innovating Clinical Trials for Amyotrophic Lateral Sclerosis: Challenging the Established Order
por: van Eijk, Ruben P.A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bdr0emrvu1ufso5p7op04d5umg